etigilimab,nivolumab
mereo biopharmaceuticalceutical,bms,marker therapeutics
['nivo', 'nivolumab', 'etigilimab', '$bmy', 'bms', 'bmsnews', '$mreo']
 eagerly waiting phase 1b/2 study of etigilimab #tigit and nivolumab #cervicalcancer cohort already reported 2 complete responses. $mreo $bmy 
No investment advice and tweets are my opinion or research that I have https://t.co/2d68PpO8Ou your own research before investing in stock market.